IRIDEX Corporation (IRIX)

Market Cap	23.21M +10.0%
Revenue (ttm)	50.65M +4.6%
Net Income	-5.09M
EPS	-0.30
Shares Out	17.19M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	63,392
Open	1.350
Previous Close	1.350
Day's Range	1.310 - 1.420
52-Week Range	0.790 - 1.648
Beta	0.65
Analysts	n/a
Price Target	n/a
Earnings Date	May 12, 2026

About IRIX

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retino...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Feb 15, 1996
• Employees: 93
• Stock Exchange: NASDAQ
• Ticker Symbol: IRIX
• Website: https://www.iridex.com

Financial Performance

In 2024, IRIDEX's revenue was $48.67 million, a decrease of -6.17% compared to the previous year's $51.87 million. Losses were -$8.91 million, -6.90% less than in 2023.